OSG on NYSE
OCTAVE SPECIALTY GROUP INC
American surety insurance company, incorporated in Delaware. Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with MBIA, ASSURED GUARANTY LTD or NMI Holdings, Inc., or pick any stock.
- TickerOSG on NYSE1
- IndustrySurety Insurance1
- HeadquartersNew York, New York1
- Incorporated inDE2
- Business address40 Wall Street, 55Th Floor, New York, Ny 100052
- Filer categoryAccelerated filer2
See how the biggest companies compare on our leaderboards
Octave Specialty Group, Inc. ("OSG"), headquartered in New York City, is a financial services holding company incorporated in the State of Delaware on April 29, 1991 and was formerly known as Ambac Financial Group, Inc. ("AFG"). In the fourth quarter of 2025, AFG changed its name and rebranded as OSG in connection with the sale of its Legacy Financial Guarantee business. References to "Octave," "OSG," the “Company,” “we,” “our,” and “us” are to OSG and its subsidiaries, as the context requires. Octave operates two principal businesses:3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Accident & Health brought in 21% of the revenue OCTAVE SPECIALTY GROUP INC broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2021 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Accident & Health | $32.8M | $30.1M | $29.6M | |
| Property | $0 | $5.1M | $22.6M | |
| Specialty Automobile | $11.9M | $17.9M | $17.4M | |
| Reinsurance | $147.0K | $1.6M | $15.7M | |
| Other Professional | $3.1M | $10.1M | $13.3M | |
| Niche Specialty Risks | $0 | $5.3M | $13.3M | |
| Surety Product Line | $0 | $2.9M | $10.3M | |
| Professional Directors And Officers Liability Insurance | $0 | $1.4M | $7.0M | |
| Miscellaneous Specialty | $363.0K | $1.7M | $5.4M | |
| Marine and Energy | $2.9M | $2.8M | $4.6M | |
| Environmental | $0 | $13.1M | $4.3M |
Business segments
Insurance Distribution brought in 65% of the revenue OCTAVE SPECIALTY GROUP INC broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2023 | 2024 | 2025 |
|---|---|---|---|
| Insurance Distribution | $51.5M | $99.2M | $163.7M |
| Specialty Property & Casualty Program | $64.1M | $126.3M | $88.4M |
Regions
United States brought in 69% of the revenue OCTAVE SPECIALTY GROUP INC broke down this way in fiscal 2025.
Regions by year
| Regions | 2023 | 2024 | 2025 |
|---|---|---|---|
| United States | $124.7M | $212.6M | $172.3M |
| United Kingdoms | $0 | $23.2M | $78.9M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Other costs83¢$119.5M
- Interest13¢$18.6M
- Income tax4¢$5.2M
Out of $143.4M in revenue.4 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net premiums earned | $67.2M | $99.0M | $51.9M |
| Commissions | $143.4M | $92.0M | $51.3M |
| Program fees | $14.3M | $13.5M | $8.4M |
| Realized Investment Gains (Losses) | -$2.6M | -$496.0K | $19.0K |
| Investment income | $10.6M | $14.4M | $13.2M |
| Net gains (losses) on derivative contracts | $1.0M | $4.0M | -$279.0K |
| Other | -$4.8M | $10.5M | -$60.0K |
| Total revenues | $251.2M | $235.8M | $124.7M |
| Loss and loss adjustment expenses | $47.2M | $72.6M | $36.7M |
| Policy acquisition costs | $15.8M | $23.7M | $10.6M |
| Commissions | $37.0M | $40.9M | $29.5M |
| General and Administrative Expense | $191.6M | $129.2M | $67.0M |
| Depreciation expense | $3.9M | $2.3M | $1.1M |
| Interest | $18.6M | $9.4M | $0 |
| Total expenses | $352.2M | $295.7M | $148.9M |
| Pretax income (loss) from continuing operations | -$101.0M | -$59.8M | -$24.2M |
| Income tax expense (benefit) | -$5.2M | -$924.0K | -$989.0K |
| Noncontrolling interest | -$2.6M | -$361.0K | -$1.3M |
| Discontinued operations | -$163.3M | -$497.2M | $28.2M |
| Net income (loss) | -$259.1M | -$556.1M | $5.0M |
| Net income (loss) attributable to shareholders | -$261.7M | -$556.4M | $3.6M |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | -$95.8M | -$58.9M | -$23.2M |
| Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, Reclassification Adjustment from AOCI for Derecognition, after Tax | $1.1M | -$356.0K | -$88.0K |
| Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax | $0 | -$4.9M | $1.6M |
| Total other comprehensive income (loss), net of income tax | $222.1M | -$28.4M | $92.8M |
| Total comprehensive income (loss), net of income tax | -$37.0M | -$584.5M | $97.7M |
| Total comprehensive income (loss) attributable to shareholders | -$64.8M | -$581.8M | $96.4M |
| Income (Loss) from Continuing Operations, Per Basic Share | -$2 | -$1 | -$0 |
| Income (Loss) from Continuing Operations, Per Diluted Share | -$2 | -$1 | -$0 |
| Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share | -$3 | -$11 | $1 |
| Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share | -$3 | -$11 | $1 |
| Basic | -$5.93 | -$11.96 | $0.18 |
| Diluted | -$5.93 | -$11.96 | $0.18 |
| Weighted Average Number of Shares Outstanding, Basic | 47.2M shares | 47.0M shares | 45.6M shares |
| Weighted Average Number of Shares Outstanding, Diluted | 47.2M shares | 47.0M shares | 45.6M shares |
| Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest | -$2.6M | -$361.0K | -$1.3M |
| Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Noncontrolling Interest | -$25.2M | $3.1M | $0 |
| Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax | $19.6M | -$939.0K | $51.2M |
| Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | $201.4M | -$22.2M | $40.1M |
| Net income (loss) from discontinued operations | -$163.3M | -$497.2M | $28.2M |
| Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic | -$98.4M | -$59.3M | -$24.6M |
| Insurance Agency Management Fee | $20.4M | $6.4M | $0 |
| Depreciation, Depletion and Amortization | $42.0M | $19.9M | $5.2M |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 5 fiscal years (annual) or 6 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2025-10-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Available-for-sale Securities | $122.3M | $157.0M | |||
| Short-term Investments | $146.4M | $127.6M | |||
| Other Investments | $25.0M | $28.3M | |||
| Investments, Total | $293.7M | $312.9M | |||
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $68.4M | $47.3M | |||
| Premiums Receivable, Net | $75.1M | $57.2M | |||
| Receivables, Net, Current | $86.5M | $55.4M | |||
| Reinsurance Recoverables, Including Reinsurance Premium Paid | $436.1M | $306.2M | |||
| Deferred ceded premium | $146.4M | $148.3M | |||
| Deferred Policy Acquisition Cost | $9.7M | $8.6M | |||
| Intangible assets, less accumulated amortization | $475.0M | $344.8M | |||
| Goodwill | $540.3M | $418.2M | $69.7M | ||
| Other assets | $92.0M | $92.3M | |||
| Disposal Group, Including Discontinued Operation, Assets | $0 | $6.3B | $7.5B | ||
| Total assets | $2.2B | $8.1B | $8.4B | ||
| Unearned premiums | $187.2M | $182.4M | |||
| Liability for Claims and Claims Adjustment Expense | $460.0M | $349.1M | |||
| Ceded premiums payable | $80.6M | $53.0M | |||
| Capitalized Contract Cost, Net | $7.0M | $7.5M | |||
| Accrued Liabilities for Commissions, Expense and Taxes | $115.6M | $71.4M | |||
| Deferred Income Tax Liabilities, Net | $65.2M | $70.1M | |||
| Short-Term Debt | $0 | $150.0M | |||
| Long-term debt | $117.6M | $100.0M | $0 | ||
| Accrued interest payable | $1.3M | $2.6M | |||
| Other liabilities | $102.8M | $89.0M | |||
| Total liabilities held-for-sale | $0 | $5.9B | |||
| Liabilities | $1.1B | $6.9B | |||
| Redeemable noncontrolling interest | $253.0M | $199.4M | $17.1M | $20.0M | |
| Preferred Stock, Value, Issued | $0 | $0 | |||
| Common Stock, Value, Issued | $489.0K | $489.0K | |||
| Additional paid-in capital | $369.9M | $331.0M | |||
| Accumulated other comprehensive income (loss) | $8.5M | -$188.4M | -$160.0M | ||
| Retained earnings | $370.4M | $683.6M | |||
| Treasury Stock, Value | -$33.5M | -$28.3M | |||
| Total Octave Specialty Group, Inc. stockholders equity | $715.8M | $798.4M | |||
| Nonredeemable noncontrolling interest | $117.4M | $197.8M | |||
| Total stockholders equity | $833.2M | $996.1M | $1.4B | $1.3B | |
| Total liabilities, redeemable noncontrolling interest and stockholders equity | $2.2B | $8.1B | |||
| Fixed income securities, amortized cost | $269.8M | $289.7M | |||
| Short-term investments, amortized cost | $146.4M | $127.6M | |||
| Other Investment Not Readily Marketable, Fair Value | $7.5M | $7.5M | |||
| Restricted Cash | $40.8M | $17.7M | |||
| Preferred stock, par value | $0.01 | ||||
| Preferred stock, shares authorized | 20.0M shares | 20.0M shares | |||
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | |||
| Common stock, shares authorized | 130.0M shares | 130.0M shares | |||
| Common stock, shares issued | 48.9M shares | 48.9M shares | |||
| Common Stock, Shares, Outstanding | 45.0M shares | ||||
| Treasury Stock, Common, Shares | 3.9M shares | 2.4M shares |
| Period ending | 2025-12-31 | 2025-10-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2013-04-30 |
|---|---|---|---|---|---|---|
| Available-for-sale Securities | $122.3M | $157.0M | ||||
| Short-term Investments | $146.4M | $127.6M | ||||
| Other Investments | $25.0M | $28.3M | ||||
| Investments, Total | $293.7M | $312.9M | ||||
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $68.4M | $47.3M | ||||
| Premiums Receivable, Net | $75.1M | $57.2M | ||||
| Receivables, Net, Current | $86.5M | $55.4M | ||||
| Reinsurance Recoverables, Including Reinsurance Premium Paid | $436.1M | $306.2M | ||||
| Deferred ceded premium | $146.4M | $148.3M | ||||
| Deferred Policy Acquisition Cost | $9.7M | $8.6M | ||||
| Intangible assets, less accumulated amortization | $475.0M | $344.8M | ||||
| Goodwill | $540.3M | $418.2M | $69.7M | |||
| Other assets | $92.0M | $92.3M | ||||
| Disposal Group, Including Discontinued Operation, Assets | $0 | $6.3B | $7.5B | |||
| Total assets | $2.2B | $8.1B | $8.4B | |||
| Unearned premiums | $187.2M | $182.4M | ||||
| Liability for Claims and Claims Adjustment Expense | $460.0M | $349.1M | ||||
| Ceded premiums payable | $80.6M | $53.0M | ||||
| Capitalized Contract Cost, Net | $7.0M | $7.5M | ||||
| Accrued Liabilities for Commissions, Expense and Taxes | $115.6M | $71.4M | ||||
| Deferred Income Tax Liabilities, Net | $65.2M | $70.1M | ||||
| Short-Term Debt | $0 | $150.0M | ||||
| Long-term debt | $117.6M | $100.0M | $0 | |||
| Accrued interest payable | $1.3M | $2.6M | ||||
| Other liabilities | $102.8M | $89.0M | ||||
| Total liabilities held-for-sale | $0 | $5.9B | ||||
| Liabilities | $1.1B | $6.9B | ||||
| Redeemable noncontrolling interest | $253.0M | $199.4M | $17.1M | $20.0M | ||
| Preferred Stock, Value, Issued | $0 | $0 | ||||
| Common Stock, Value, Issued | $489.0K | $489.0K | ||||
| Additional paid-in capital | $369.9M | $331.0M | ||||
| Accumulated other comprehensive income (loss) | $8.5M | -$188.4M | -$160.0M | |||
| Retained earnings | $370.4M | $683.6M | ||||
| Treasury Stock, Value | -$33.5M | -$28.3M | ||||
| Total Octave Specialty Group, Inc. stockholders equity | $715.8M | $798.4M | ||||
| Nonredeemable noncontrolling interest | $117.4M | $197.8M | ||||
| Total stockholders equity | $833.2M | $996.1M | $1.4B | $1.3B | ||
| Total liabilities, redeemable noncontrolling interest and stockholders equity | $2.2B | $8.1B | ||||
| Fixed income securities, amortized cost | $269.8M | $289.7M | ||||
| Short-term investments, amortized cost | $146.4M | $127.6M | ||||
| Other Investment Not Readily Marketable, Fair Value | $7.5M | $7.5M | ||||
| Restricted Cash | $40.8M | $17.7M | ||||
| Preferred stock, par value | $0.01 | $0.01 | ||||
| Preferred stock, shares authorized | 20.0M shares | 20.0M shares | ||||
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | ||||
| Common stock, par value | $0.01 | |||||
| Common stock, shares authorized | 130.0M shares | 130.0M shares | ||||
| Common stock, shares issued | 48.9M shares | 48.9M shares | ||||
| Common Stock, Shares, Outstanding | 45.0M shares | |||||
| Treasury Stock, Common, Shares | 3.9M shares | 2.4M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income (loss) | -$259.1M | -$556.1M | $5.0M |
| Net income (loss) from discontinued operations | -$163.3M | -$497.2M | $28.2M |
| Noncontrolling interest | -$2.6M | -$361.0K | -$1.3M |
| Net income (loss) from continuing operations | -$95.8M | -$58.9M | -$23.2M |
| Depreciation, Depletion and Amortization | $42.0M | $19.9M | $5.2M |
| Share-based compensation | $9.7M | $9.4M | $12.3M |
| Deferred Income Taxes and Tax Credits | -$2.5M | -$633.0K | -$1.5M |
| Unearned premiums, net | $6.7M | -$10.3M | $27.9M |
| Unearned premiums, net | -$19.0M | $10.8M | $23.7M |
| Ceded premiums payable | $27.6M | $23.3M | $9.7M |
| Premium and commissions receivables | -$49.6M | -$11.3M | -$30.2M |
| Amortization of intangible assets | $38.0M | $17.6M | $4.2M |
| Corporate costs reallocated to continuing operations | $6.8M | $14.9M | $19.4M |
| Other, net | -$11.3M | $6.2M | -$7.8M |
| Net cash provided by (used in) operating activities from continuing operations | -$52.3M | $762.0K | $36.9M |
| Proceeds from sales of bonds | $27.4M | $6.0M | $1.4M |
| Proceeds from matured bonds | $37.7M | $21.6M | $15.1M |
| Purchases of bonds | -$25.6M | -$60.5M | -$33.2M |
| Proceeds from Sale and Maturity of Other Investments | $0 | $625.0K | $0 |
| Purchases of other investments | -$66.0K | -$2.5M | -$2.2M |
| Change in short-term investments | -$18.8M | $101.8M | $4.2M |
| Acquisitions, net of cash acquired | -$217.9M | -$243.8M | -$7.0M |
| Proceeds from sale of subsidiary | $407.3M | $14.1M | $0 |
| Other, net | -$10.1M | -$3.8M | -$4.9M |
| Net cash provided by (used in) investing activities from continuing operations | $199.9M | -$166.4M | -$26.7M |
| Proceeds from issuance of long term debt | $117.5M | ||
| Proceeds from short-term debt | $0 | $147.0M | $0 |
| Issuance of Equity Interest in Subsidiary | $62.0M | ||
| Payments for Repurchase of Common Stock | -$29.9M | -$11.7M | -$4.5M |
| Payment, Tax Withholding, Share-based Payment Arrangement | -$5.3M | -$692.0K | -$4.6M |
| Payment for Debt Extinguishment or Debt Prepayment Cost | -$150.0M | ||
| Issuance of Warrants in Connection with Sale of Subsidiary | $17.0M | ||
| Payments to Noncontrolling Interests | -$71.3M | -$3.0M | |
| Distributions to noncontrolling interest holders | -$4.2M | -$2.4M | -$1.9M |
| Net cash provided by (used in) financing activities from continuing operations | -$126.3M | $194.2M | -$11.0M |
| Net cash provided by (used in) continuing operations | $22.8M | $28.1M | -$717.0K |
| Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | $1.5M | -$558.0K | $0 |
| Net cash provided by (used in) operating activities from discontinued operations | $71.7M | $33.5M | $163.4M |
| Net cash provided by (used in) investing activities from discontinued operations | $69.7M | -$7.9M | $461.9M |
| Net cash provided by (used in) financing activities from discontinued operations | -$143.1M | -$214.6M | -$411.9M |
| Net cash provided by (used in) discontinued operations | -$1.7M | -$189.0M | $213.3M |
| Effect of foreign exchange on cash and cash equivalents - discontinued operations | $0 | -$126.0K | $529.0K |
| Net cash provided by (used in) discontinued operations | -$1.7M | -$189.1M | $213.8M |
| Cash Provided by (Used in) Financing Activity, Including Discontinued Operation | $21.4M | $28.6M | -$717.0K |
| Net income (loss) attributable to shareholders | -$261.7M | -$556.4M | $3.6M |
| Increase (Decrease) in Reserve for Commissions, Expense and Taxes | $30.7M | -$3.2M | $0 |
No quarter-by-quarter statement was filed.
Leadership
Who has led OCTAVE SPECIALTY GROUP INC, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
- Chief executive officerClaude Leblanc Jan 5, 2017 to now12
- Chief executive officerTavakoli Nader Jan 5, 2016 to Sep 20, 201613
- Chief executive officerDiana Adams May 1, 2013 to Dec 22, 201414
- Chief executive officerDavid W. Wallis Jan 27, 2009 to Mar 22, 201115
- Chief executive officerMichael A. Callen Mar 7, 2008 to Dec 5, 200816
- Chief executive officerRobert J. Genader Jan 25, 2006 to Dec 7, 200717
- ChairMichael A. Callen Mar 7, 2008 to Dec 1, 201016
- ChairRobert J. Genader Aug 24, 2006 to Dec 7, 200718
- PresidentDavid W. Wallis Jan 27, 2009 to Mar 22, 201115
- PresidentMichael A. Callen Mar 7, 2008 to Dec 5, 200816
- PresidentRobert J. Genader Jan 25, 2006 to Dec 7, 200717
- Chief financial officerDavid Trick Jan 15, 2010 to now19
- Chief financial officerSean T. Leonard Mar 2, 2006 to Apr 3, 200920
- Chief operating officerR. Sharon Smith Oct 3, 2025 to now21
- Chief operating officerDaniel McGinnis Dec 22, 2021 to Oct 3, 202522
Board members and other officers (44)
- Chief Accounting OfficerCristina E. Ahn Sep 30, 2025 to now23
- OfficerLawrence F. Metz Dec 17, 2025 to now24
- Senior Managing DirectorR. Sharon Smith May 24, 2017 to now25
- Interim Chief Exec. OfficerTavakoli Nader Apr 3, 2015 to Dec 15, 201526
- Senior Managing DirectorDavid Trick May 1, 2013 to May 1, 201327
- Senior Managing DirectorCathleen Matanle Nov 20, 2012 to May 1, 201328
- Senior Managing DirectorIain H. Bruce Nov 20, 2012 to Nov 20, 201229
- Senior Managing DirectorDavid Barranco Nov 21, 2012 to now30
- Senior Managing Director, GCStephen Michael Ksenak Sep 16, 2011 to May 1, 201331
- Senior Managing DirectorGregory G. Raab Mar 10, 2009 to Mar 10, 200932
- Managing Director, ControllerRobert Bryan Eisman Dec 8, 2009 to now33
- Senior Managing DirectorDiana Adams Jun 19, 2008 to Mar 22, 201234
- Senior Vice PresidentGregg L. Bienstock Jan 6, 2006 to Jun 30, 201035
- Senior Managing DirectorDavid W. Wallis Jan 25, 2006 to Dec 5, 200836
- Executive Vice PresidentJohn W. Uhlein Jan 25, 2006 to Sep 5, 200837
- Senior Managing DirectorKathleen A. McDonough Jan 25, 2006 to Jan 28, 200838
- Senior Vice PresidentKevin J. Doyle Jan 25, 2006 to Mar 4, 201139
- Senior Managing DirectorMiller Douglas C. Renfield Jan 25, 2006 to Jan 27, 200940
- Senior Managing DirectorRobert G. Shoback Jan 25, 2006 to Feb 2, 200941
- Senior Managing DirectorThomas J. Gandolfo Jan 25, 2006 to Mar 7, 200842
- Board memberKristi Ann Matus Jun 22, 2023 to now43
- Board memberLisa G. Iglesias Aug 4, 2021 to now44
- Board memberJoan M. Lammtennant Mar 1, 2018 to now45
- Board memberClaude Leblanc Jan 5, 2017 to now12
- Board memberC. James Prieur Jan 5, 2016 to Jan 4, 202346
- Board memberDavid Herzog Mar 31, 2016 to Apr 4, 202347
- Board memberIan David Haft Mar 31, 2016 to now48
- Board memberAlexander David Greene Apr 6, 2015 to May 13, 202149
- Board memberDiana Adams Jan 29, 2013 to Dec 22, 201450
- Board memberVictor E. Mandel May 10, 2013 to May 1, 201551
- Board memberTavakoli Nader May 13, 2013 to Sep 20, 201652
- Board memberEugene M. Bullis Jun 6, 2013 to May 1, 201553
- Board memberDavid W. Wallis Jan 27, 2009 to Mar 22, 201215
- Board memberPaul R. Derosa Jul 9, 2008 to Jan 6, 201054
- Board memberPhilip N. Duff May 8, 2007 to May 7, 200955
- Board memberRobert J. Genader Jan 25, 2006 to Jun 9, 200617
- Board memberPhillip B. Lassiter Jan 31, 2006 to Mar 9, 200756
- Board memberHenry D. G. Wallace Mar 3, 2006 to Nov 23, 201057
- Board memberJill M. Considine Mar 3, 2006 to May 7, 200958
- Board memberLaura S. Unger Mar 3, 2006 to May 7, 200959
- Board memberMichael A. Callen Mar 3, 2006 to Dec 7, 200760
- Board memberThomas C. Theobald Mar 3, 2006 to Apr 9, 201261
- Board memberW. Grant Gregory Mar 3, 2006 to Dec 7, 200762
- General counselStephen Michael Ksenak Dec 23, 2013 to now63
Former names
Timeline
- Jan 5, 2017New chief executive Claude Leblanc becomes CEO12
- Jan 5, 2016New chief executive Tavakoli Nader becomes CEO13
- May 1, 2013New chief executive Diana Adams becomes CEO14
- Jan 27, 2009New chief executive David W. Wallis becomes CEO15
- Mar 7, 2008New chief executive Michael A. Callen becomes CEO16
- Jan 25, 2006New chief executive Robert J. Genader becomes CEO17
Filings
434 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 58 major events, 306 insider forms, 24 large holders, 26 other. The latest 20:
- Oct 6, 20264 EDGAR
- Oct 6, 20264 EDGAR
- Oct 6, 20264 EDGAR
- Oct 5, 20264 EDGAR
- Oct 5, 20264 EDGAR
- Oct 5, 20264 EDGAR
- Oct 5, 20264 EDGAR
- Oct 5, 20264 EDGAR
- Oct 5, 20264 EDGAR
- Aug 6, 2026S-8 EDGAR
- Aug 6, 2026S-8 POS EDGAR
- Aug 6, 202610-Q EDGAR
- Aug 6, 20268-K EDGAR
- Jul 31, 2026SCHEDULE 13G EDGAR
- Jul 13, 20264 EDGAR
- Jul 13, 20264 EDGAR
- Jul 13, 20264 EDGAR
- Jul 7, 20264 EDGAR
- Jul 7, 20264 EDGAR
- Jul 7, 20264 EDGAR
The 434 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
26 open-market trades by officers, directors and large owners since October 2021: 26 buys and 0 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jan 2, 2026 | LeBlanc ClaudeChief Executive Officer | Buy | 12,000 | $7.59 | $91.1K | Form 4 |
| Nov 12, 2025 | Smith R SharonExec VP & Group COO | Buy | 20 | $10.25 | $205 | Form 4 |
| Oct 1, 2025 | LeBlanc ClaudeChief Executive Officer | Buy | 25,000 | $8.54 | $213.5K | Form 4 |
| Aug 11, 2025 | LeBlanc ClaudeChief Executive Officer | Buy | 25,000 | $7.03 | $175.8K | Form 4 |
| May 14, 2025 | Stein Jeffrey ScottDirector | Buy | 15,000 | $6.46 | $96.9K | Form 4 |
| May 14, 2025 | PRICE MICHAEL DDirector | Buy | 76,986 | $6.49 | $499.6K | Form 4 |
| May 14, 2025 | LeBlanc ClaudeChief Executive Officer | Buy | 40,000 | $6.50 | $260.0K | Form 4 |
| Sep 27, 2024 | Matus Kristi AnnDirector | Buy | 6,300 | $11.16 | $70.3K | Form 4 |
| Sep 26, 2024 | Matus Kristi AnnDirector | Buy | 2,700 | $11.27 | $30.4K | Form 4 |
| Aug 8, 2024 | Smith R SharonExec VP & Group COO | Buy | 1,100 | $10.64 | $11.7K | Form 4 |
| Aug 7, 2024 | Stein Jeffrey ScottDirector | Buy | 25,000 | $10.82 | $270.5K | Form 4 |
| Aug 7, 2024 | PRICE MICHAEL DDirector | Buy | 89,312 | $11.19 | $999.5K | Form 4 |
| Aug 7, 2024 | LeBlanc ClaudeChief Executive Officer | Buy | 25,000 | $10.83 | $270.9K | Form 4 |
| Aug 7, 2024 | Trick DavidExec VP, CFO & Treasurer | Buy | 3,700 | $10.76 | $39.8K | Form 4 |
| Aug 7, 2024 | Ksenak Stephen MichaelSr. MD & General Counsel | Buy | 5,000 | $11.00 | $55.0K | Form 4 |
| Sep 1, 2023 | LeBlanc ClaudeChief Executive Officer | Buy | 2,500 | $13.29 | $33.2K | Form 4 |
| May 20, 2022 | Smith R SharonExec VP & Group COO | Buy | 1,000 | $10.05 | $10.1K | Form 4 |
| May 13, 2022 | PRIEUR C JAMESDirector | Buy | 5,004 | $8.45 | $42.3K | Form 4 |
| May 13, 2022 | LeBlanc ClaudeChief Executive Officer | Buy | 3,000 | $8.72 | $26.2K | Form 4 |
| May 13, 2022 | PRIEUR C JAMESDirector | Buy | 10,000 | $8.43 | $84.3K | Form 4 |
All 26 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- VANGUARD CAPITAL MANAGEMENT LLCSCHEDULE 13G, 1 filing Jul 31, 202664
- JANE STREET GROUP, LLCSCHEDULE 13G/A, 2 filings Feb 11, 2026 to May 11, 202665
- Western Standard LLCSCHEDULE 13G/A, 2 filings Feb 12, 2026 to May 11, 202666
- VANGUARD GROUP INCSCHEDULE 13G/A, 8 filings Feb 9, 2022 to Mar 27, 202667
- SUSQUEHANNA SECURITIES, LLCSCHEDULE 13G/A, 2 filings Aug 14, 2025 to Nov 13, 202568
- BlackRockSCHEDULE 13G/A, 1 filing Oct 17, 202569
- DIMENSIONAL FUND ADVISORS LPSCHEDULE 13G/A, 2 filings Feb 9, 2024 to Oct 9, 202570
- Theodore Walker Cheng-De KingSC 13G, 1 filing Apr 5, 202471
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 4,572,516 | $28.5M | 0.0% | +654,718 |
| Western Standard LLC | 2,247,591 | $14.0M | 4.8% | No change |
| Vanguard Capital Management LLC | 1,972,619 | $12.3M | 0.0% | +27,543 |
| Prescott Group Capital Management, L.L.C. | 1,647,793 | $10.3M | 0.9% | +55,206 |
| Third Avenue Management LLC | 1,341,879 | $8.4M | 1.3% | +668 |
| Bain Capital Credit, LP | 1,108,012 | $6.9M | 1.9% | No change |
| Geode Capital Management, LLC | 1,106,335 | $6.9M | 0.0% | +83,897 |
| State Street Corp | 898,673 | $5.6M | 0.0% | −42,731 |
| Dimensional Fund Advisors LP | 716,947 | $4.5M | 0.0% | −593,185 |
| Jacobs Levy Equity Management, Inc | 649,530 | $4.1M | 0.0% | −234,742 |
| Marshall Wace, Llp | 601,796 | $3.8M | 0.0% | −463,539 |
| Zacks Investment Management | 590,370 | $3.7M | 0.0% | New |
| Bracebridge Capital, LLC | 579,234 | $3.6M | 0.8% | No change |
| Morgan Stanley | 569,563 | $3.6M | 0.0% | +334,317 |
| Goldman Sachs Group Inc | 560,756 | $3.5M | 0.0% | +214,463 |
| RIHO Partners, LLC | 554,818 | $3.5M | 1.9% | +8,249 |
| Essex Investment Management Co LLC | 539,289 | $3.4M | 0.4% | +121,086 |
| Gendell Jeffrey L | 494,092 | $3.1M | 0.0% | −919,120 |
| Wolf Hill Capital Management, LP | 480,187 | $3.0M | 0.3% | −990,147 |
| Nuveen, LLC | 428,165 | $2.7M | 0.0% | −372,088 |
| Citadel Advisors LLC | 422,777 | $2.6M | 0.0% | −9,032 |
| Caption Management, LLC | 419,136 | $2.6M | 0.1% | −223,461 |
| Vanguard Portfolio Management LLC | 392,350 | $2.4M | 0.0% | +96,450 |
| Charles Schwab Investment Management Inc | 377,869 | $2.4M | 0.0% | +82,525 |
| Northern Trust Corp | 352,680 | $2.2M | 0.0% | +30,332 |
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14SEC EDGARDiana Adams, Chief executive officer
- 15
- 16
- 17
- 18SEC EDGARRobert J. Genader, Chair
- 19SEC EDGARDavid Trick, Chief financial officer
- 20
- 21
- 22
- 23
- 24SEC EDGARLawrence F. Metz, Officer
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43SEC EDGARKristi Ann Matus, Board member
- 44SEC EDGARLisa G. Iglesias, Board member
- 45SEC EDGARJoan M. Lammtennant, Board member
- 46SEC EDGARC. James Prieur, Board member
- 47SEC EDGARDavid Herzog, Board member
- 48SEC EDGARIan David Haft, Board member
- 49SEC EDGARAlexander David Greene, Board member
- 50SEC EDGARDiana Adams, Board member
- 51SEC EDGARVictor E. Mandel, Board member
- 52SEC EDGARTavakoli Nader, Board member
- 53SEC EDGAREugene M. Bullis, Board member
- 54SEC EDGARPaul R. Derosa, Board member
- 55SEC EDGARPhilip N. Duff, Board member
- 56SEC EDGARPhillip B. Lassiter, Board member
- 57SEC EDGARHenry D. G. Wallace, Board member
- 58SEC EDGARJill M. Considine, Board member
- 59SEC EDGARLaura S. Unger, Board member
- 60SEC EDGARMichael A. Callen, Board member
- 61SEC EDGARThomas C. Theobald, Board member
- 62SEC EDGARW. Grant Gregory, Board member
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71